The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Clinical value of preoperative CEA and CA15 -3 in breast cancer
Author(s): 
Pages: 1610-1613
Year: Issue:  8
Journal: Journal of Modern Oncology

Keyword:  乳腺肿瘤CA15-3CEA肿瘤标志物;
Abstract: 目的:探讨术前CEA和CA15 -3对乳腺癌早期诊断的价值及其与临床病理因素的相关性.方法:回顾性分析2000年-2005年1028例乳腺癌患者的CEA、CA15 -3水平以及与临床病理因素的关系.结果:CEA、CA15 -3联合检测、CA15 -3及CEA单独检测对乳腺癌的早期诊断敏感性均低,分别为20.9%、15.3%、9.5%;CA15-3和CEA联合检测在肝、骨和肺转移的阳性率则分别为86.7%、90.9%、45.5%(P=0.030),CA15 -3、CEA单独检测对转移病灶的敏感性无差异(P均>0.05).CEA、CA15 -3单独检测及CEA、CA15 -3联合检测的阳性率与乳腺癌的临床分期、T分期、N分期呈正相关性,(P均<0.001).CEA单独检测的阳性率与年龄>45岁、绝经后、ER阴性、PR阴性、Her2阳性有显著相关性(P均<0.05);除CEA、CA15 -3联合检测的阳性率与Her2阳性呈正相关,联合检测及CA15 -3单独检测与其他因素无相关性.结论:术前CEA和CA15 -3对乳腺癌的早期诊断缺乏敏感性,但可作为预测预后的重要指标.
Related Articles
loading...